510(k) Report

510(k) · Cleared

Cleared

Immage Immunochemistry System Lipoprotein (a) Lpax Reagent, Array System Lipoprotein (a) Lpa Reagent, Lipoprotein (a) Calib

K000121510(k) TraditionalCleared May 17, 2000120-day reviewClass II21 CFR 866.5600

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Beckman Coulter, Inc. · DFC Lipoprotein, Low-Density, Antigen, Antiserum, Control

Cleared on May 17, 2000 after a 120-day review. FDA has not posted a summary or statement for it, so its predicates are not known. 9 later devices descend from it.

Decided
May 17, 2000
Review
120 days
Class
Class II
Product code
DFC
Recalls
None
Predicates
0

9 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2001: 1 descendant cleared2002: 1 descendant cleared2005: 2 descendants cleared2003: 1 descendant cleared2014: 1 descendant cleared2013: 1 descendant cleared2007: 1 descendant cleared2008: 1 descendant cleared200020052010201520202025
  1. This deviceK000121 Immage Immunochemistry System Lipoprotein (a) Lpax Reagent, Array…Beckman Coulter, Inc. · 2000
  2. Descendant · cites it directly · 7 of its ownK013128 N Latex LP (a)Dade Behring, Inc. · 2002
  3. Descendant · 2 generations on · 4 of its ownK030477 Diadexus Plac TestDiadexus, Inc. · 2003 · Recalled
  4. Descendant · 3 generations on · 2 of its ownK050029 Cardiompo TestPrognostix, Inc. · 2005
  5. Descendant · 2 generations on · 1 of its ownK050487 Quantia LA (a)Biokit, S.A. · 2005
  6. Descendant · 3 generations on · 0 of its ownK141575 Plac Test for LP-PLA2 ActivityDiadexus, Inc. · 2014

Showing 5 of 9 descendants. See all descendants

Descendants cleared per year

2001: 12002: 12003: 12005: 22007: 12008: 12013: 12014: 1
2001high 2 (2005) · low 0 (2004)2026

Most influential descendants

Showing 5 of 9 · See all
  • K013128N Latex LP (a)Dade Behring, Inc. · 2002 · cites it directly7descendants
  • K030477Diadexus Plac TestDiadexus, Inc. · 2003 · 2 generations on4descendants
  • K050029Cardiompo TestPrognostix, Inc. · 2005 · 3 generations on2descendants
  • K050487Quantia LA (a)Biokit, S.A. · 2005 · 2 generations on1descendant
  • K141575Plac Test for LP-PLA2 ActivityDiadexus, Inc. · 2014 · 3 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K000121Immage Immunochemistry System Lipoprotein (a) Lpax Reagent, Array System…Beckman Coulter, Inc.2000—
+1K013128N Latex LP (a)Dade Behring, Inc.2002—
+2K030477Diadexus Plac TestDiadexus, Inc.20032
+3K050029Cardiompo TestPrognostix, Inc.2005—
+2K050487Quantia LA (a)Biokit, S.A.2005—
+3K141575Plac Test for LP-PLA2 ActivityDiadexus, Inc.2014—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200110
200210
200310
200520
200710
200810
201310
201410
FIG. 1 — Lineage of K000121, 2000–2014Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DFC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DFC device

  1. #1 K253069 Lipoprotein (a) Molarity Assayscore 11.5 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA has not posted a summary or statement for it, so its predicates are not known.

What descends from it? (9)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K013128N Latex LP (a)Dade Behring, Inc.20027
K013126N LP (a) Standard SYDade Behring, Inc.20010

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K013128 (Dade Behring, Inc., 2002) has gone furthest, with 7 descendants of its own.

How does its category compare?

All DFC devices

DFC Lipoprotein, Low-Density, Antigen, Antiserum, Control: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DFC

1in 2025

2007: 12009: 12012: 22018: 12022: 12025: 12026 (partial year): 1
2007high 2 (2012) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DFC

Too few DFC 510(k)s in any year since 2007 to give a median.

Recalls per year · DFC

2in 2024

2012: 12024: 2
2007high 2 (2024) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DFC

7in 2025

2016: 12023: 62024: 162025: 7
2007high 16 (2024) · low 0 (2007)2025

MAUDE reports naming product code DFC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20080—00
20091—00
20100—00
20110—00
20122—10
20130—00
20140—00
20150—00
20160—01
20170—00
20181—00
20190—00
20200—00
20210—00
20221—00
20230—06
20240—216
20251—07
20261—0—
Cite this page

510(k) Report. “K000121: Immage Immunochemistry System Lipoprotein (a) Lpax Reagent, Array System Lipoprotein (a) Lpa Reagent, Lipoprotein (a) Calib.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K000121

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026